These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Problems of the amyloid beta precursor protein in pathogenesis of the Alzheimer type dementia]. Shoji M; Hirai S Nihon Ronen Igakkai Zasshi; 1996 Mar; 33(3):164-8. PubMed ID: 8648890 [No Abstract] [Full Text] [Related]
23. Alzheimer's disease amyloid hypothesis at crossroads: where do we go from here? Saxena U Expert Opin Ther Targets; 2010 Dec; 14(12):1273-7. PubMed ID: 21058918 [TBL] [Abstract][Full Text] [Related]
24. The 12-15-lipoxygenase is a modulator of Alzheimer's-related tau pathology in vivo. Giannopoulos PF; Joshi YB; Chu J; Praticò D Aging Cell; 2013 Dec; 12(6):1082-90. PubMed ID: 23862663 [TBL] [Abstract][Full Text] [Related]
25. Involvement of 5-lipoxygenase activating protein in the amyloidotic phenotype of an Alzheimer's disease mouse model. Chu J; Praticò D J Neuroinflammation; 2012 Jun; 9():127. PubMed ID: 22697885 [TBL] [Abstract][Full Text] [Related]
26. Anesthetics promoting in vitro AβPP metabolism and amyloid-β toxicity. Eckel B; Blobner M; Rammes G J Alzheimers Dis; 2010; 22 Suppl 3():21-6. PubMed ID: 20858965 [TBL] [Abstract][Full Text] [Related]
27. Abeta conformational change is central to Alzheimer's disease. Holtzman DM Neurobiol Aging; 2002; 23(6):1085-8. PubMed ID: 12470806 [No Abstract] [Full Text] [Related]
28. Absence of 12/15 lipoxygenase reduces brain oxidative stress in apolipoprotein E-deficient mice. Chinnici CM; Yao Y; Ding T; Funk CD; Praticò D Am J Pathol; 2005 Nov; 167(5):1371-7. PubMed ID: 16251421 [TBL] [Abstract][Full Text] [Related]
29. Overexpression of 12/15-lipoxygenase increases anxiety behavior in female mice. Joshi YB; Di Meco A; Praticò D Neurobiol Aging; 2014 May; 35(5):1032-6. PubMed ID: 24300237 [TBL] [Abstract][Full Text] [Related]
31. Additive anti-atherogenic effect of thromboxane receptor antagonism with 12/15lipoxygenase gene disruption in apolipoprotein E-deficient mice. Tang L; Ding T; Praticò D Atherosclerosis; 2008 Aug; 199(2):265-70. PubMed ID: 18206890 [TBL] [Abstract][Full Text] [Related]
32. The amyloid cascade hypothesis has misled the pharmaceutical industry. Biochem Soc Trans; 2011 Aug; 39(4):920-3. PubMed ID: 21787324 [TBL] [Abstract][Full Text] [Related]
33. Amyloid-beta: a (life) preserver for the brain. Obrenovich ME; Joseph JA; Atwood CS; Perry G; Smith MA Neurobiol Aging; 2002; 23(6):1097-9. PubMed ID: 12470809 [No Abstract] [Full Text] [Related]
34. Emerging role of 12/15-Lipoxygenase (ALOX15) in human pathologies. Singh NK; Rao GN Prog Lipid Res; 2019 Jan; 73():28-45. PubMed ID: 30472260 [TBL] [Abstract][Full Text] [Related]
35. Testing times for the "amyloid cascade hypothesis". Hardy J Neurobiol Aging; 2002; 23(6):1073-4. PubMed ID: 12470803 [No Abstract] [Full Text] [Related]
36. Is amyloid beta-peptide neurotoxic or neuroprotective and what is its role in the binding of metal ions? Savory J; Ghribi O; Herman MM Neurobiol Aging; 2002; 23(6):1089-92. PubMed ID: 12470807 [No Abstract] [Full Text] [Related]
37. Bioflocculant hypothesis: a partial endorsement. Terry R Neurobiol Aging; 2002; 23(6):1075. PubMed ID: 12470804 [No Abstract] [Full Text] [Related]
38. Evolution and the scientific method. Tucker HM; Estus S Neurobiol Aging; 2002; 23(6):1093-5. PubMed ID: 12470808 [No Abstract] [Full Text] [Related]
39. Nardilysin, ADAM10, and Alzheimer's disease: of mice and men. Bernstein HG; Steiner J; Bogerts B; Stricker R; Reiser G Neurobiol Aging; 2014 Mar; 35(3):e1. PubMed ID: 24099785 [No Abstract] [Full Text] [Related]
40. Alzheimer's disease in man and transgenic mice: females at higher risk. Turner RS Am J Pathol; 2001 Mar; 158(3):797-801. PubMed ID: 11238027 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]